M. Faber

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).

C. Punt, M. Campone, M. Ravic, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.

M. Piccart, J. Verweij, A. Sparreboom, 2001, Journal of Clinical Oncology.

Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.

M. Piccart, J. Verweij, A. Sparreboom, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors.

J. Wanders, M. Ravic, P. Fumoleau, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG).

J. Wanders, M. Ravic, J. Schellens, 2003, European journal of cancer.

Phase I and Pharmacokinetic Study of E 7070 , a Chloroindolyl-Sulfonamide Anticancer Agent , Administered on a Weekly Schedule to Patients with Solid Tumors

J. Wanders, M. Ravic, P. Fumoleau, 2003 .

Nutritional content and a phase-I safety clinical trial of a herbal-nutritional supplement (IMUNITI) with putative immune-modulating properties.

M. Matsabisa, M. Sekhoacha, M. Faber, 2012, African journal of traditional, complementary, and alternative medicines : AJTCAM.

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.

M. Piccart, J. Wanders, J. Verweij, 2002, European journal of cancer.